IBRN ETF Price & Analysis
IBRN ETF Chart & Stats
$32.08
--
Market closed
$32.08
--
Day’s Range― - ―
52-Week Range$17.86 - $37.00
Previous Close$32.08
VolumeN/A
Average Volume (3M)1.92K
AUM4.62M
NAV32.09
Expense Ratio0.47%
Holdings Count75
Beta1.12
Inception DateAug 24, 2022
Last Dividend Ex-Date
Dec 16, 2025Dividend Yield
(1%)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume1,571
30 Day Avg. Volume1,916
AlphaN/A
ETF Overview
iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF (IBRN) is an innovative investment vehicle designed for those looking to capitalize on the dynamic and rapidly evolving field of health care, with a specialized focus on the neuroscience and life sciences sectors. This ETF offers investors targeted exposure to companies at the forefront of pharmaceutical, biotechnology, and life sciences advancements, particularly those spearheading breakthroughs in neurological research and treatments. As a sector-focused fund, IBRN stands out for its commitment to capturing growth within the pharma, biotech, and life sciences niche, offering a diversified portfolio of firms that are pioneering in medical innovation and technology. Investors in IBRN gain access to a carefully curated selection of enterprises that are not only shaping the future of health care but are also poised to benefit from the increasing global demand for advanced neurological solutions and therapies. With its emphasis on cutting-edge research and development, the iShares Neuroscience and Healthcare ETF represents a compelling opportunity for investors seeking to align their portfolios with the next wave of health care transformation.
iShares Neuroscience and Healthcare ETF (IBRN) Fund Flow Chart
iShares Neuroscience and Healthcare ETF (IBRN) 1 year Net Flows: $0
IBRN ETF News
IBRN ETF FAQ
What was IBRN’s price range in the past 12 months?
IBRN lowest ETF price was $17.86 and its highest was $37.00 in the past 12 months.
What is the AUM of IBRN?
As of Mar 25, 2026 The AUM of IBRN is 4.62M.
Is IBRN overvalued?
According to Wall Street analysts IBRN’s price is currently Undervalued.
Does IBRN pay dividends?
IBRN pays a Annually dividend of $0.32 which represents an annual dividend yield of 1%. See more information on IBRN dividends here
How many shares outstanding does IBRN have?
Currently, no data Available
Which hedge fund is a major shareholder of IBRN?
Currently, no hedge funds are holding shares in IBRN
IBRN ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Xenon Pharmaceuticals
5.17%
PTC Therapeutics
4.21%
Biogen Inc.
3.96%
Neurocrine Biosciences
3.95%
Alkermes plc
3.86%
Axsome Therapeutics Inc.
3.85%
Scholar Rock Holding
3.84%
Argenx
3.78%
Arrowhead Pharmaceuticals, Inc.
3.78%
ACADIA Pharmaceuticals Inc.
3.78%
Total40.11%
See All Holdings
